Login / Signup

Dose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation.

Eileen DeusterJohn A TomensonFahim MohamedIndika Bandara GawarammanaNicholas Alan BuckleyMartin F WilksMichael Eddleston
Published in: Clinical toxicology (Philadelphia, Pa.) (2022)
Importantly, we found good agreement between reported dose ingested and plasma paraquat concentration, case fatality, and time to death, suggesting that the reported dose is a valid marker for the dose ingested. Vomiting occurred within 30 min for 68.5% of patients, exceeding the characteristics for a purported effective emetic in the FAO specifications. However, vomiting within 30 min was associated with approximately double the risk of death compared to those who did not vomit, larger paraquat ingestions, and higher blood paraquat concentrations. In addition, death occurred in many patients who did not vomit, and the proportion vomiting within 30 min only reached 82.1% for the highest ingested dose group. Overall, we found no evidence of benefit resulting from incorporation of the emetic, suggesting that the current FAO specification is not effective at preventing deaths after ingestion of the paraquat SL formulation.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • drug delivery
  • chemotherapy induced
  • prognostic factors
  • pulmonary fibrosis
  • abdominal pain
  • patient reported